美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Skye Bioscience Inc.

2.11

+0.12006.03%

盤後：2.150.0400+1.90%19:19 EDT

成交量：3.70萬

成交額：7.50萬

市值：926.47萬

市盈率：-0.21

高：2.11

開：1.97

低：1.90

收：1.99

52周最高：39.92

52周最低：1.64

股本：439.09萬

流通股本：286.90萬

量比：0.41

換手率：1.29%

股息：- -

股息率：- -

每股收益(TTM):-10.2399

每股收益(LYR):-11.2801

淨資產收益率：-233.87%

總資產收益率：-95.06%

市淨率：-18.63

市盈率(LYR):-0.19

資料載入中...

總覽公司新聞資訊公告

Skye Bioscience Inc.首席財務官John P. Sharp宣佈辭職，9月8日正式生效，SEC文件披露

Skye Bioscience與Redmile Biopharma Investments III簽署2200萬美元證券購買協議——SEC文件披露

Skye Bioscience：合併後公司現金儲備預計可支撐運營至2029年，Rxc008二期數據預計2028年下半年公布

Skye Bioscience股東將獲CVR：交易結束後12個月內有權收取Nimacimab淨收益的90%

Skye Bioscience交易後股權結構：Skye持股5.38%，Redx持46.17%，融資投資者持48.45%

Skye Bioscience Inc. - 臨床研究委員會批准啓動第二組（600毫克靜脈注射）入組，此前第一組安全性評估結果良好

Skye宣佈基於隊列1前四名受試者良好安全性數據，隊列評審委員會批准開啓隊列2

美國研究綜述-Accuray、Aevex、Zoetis

BUZZ--美國股票走勢-特斯拉、藍貓頭鷹、福特

BUZZ-斯凱生物科學公司開始測試更大劑量的肥胖症藥物，業績上升

Skye Bioscience啓動尼瑪西單抗高劑量擴展研究首位患者給藥評估暴露-反應為GLP-1聯合療法二期B階段劑量選擇提供依據

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/SKYE/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SKYE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SKYE\",,,,,undefined,":{"symbol":"SKYE","market":"US","secType":"STK","nameCN":"Skye Bioscience Inc.","latestPrice":2.11,"timestamp":1789502400000,"preClose":1.99,"halted":0,"volume":36993,"hourTrading":{"tag":"盘后","latestPrice":2.15,"preClose":2.11,"latestTime":"19:19 EDT","volume":187,"amount":401.730043,"timestamp":1789514344945,"change":0.04,"changeRate":0.018957,"amplitude":0.018957},"delay":0,"changeRate":0.060301507537688384,"floatShares":2868950,"shares":4390860,"eps":-10.239864,"marketStatus":"盤後交易","change":0.12,"latestTime":"09-15 19:20:00 EDT","open":1.97,"high":2.11,"low":1.9,"amount":75024.3047268,"amplitude":0.105528,"askPrice":2.44,"askSize":81,"bidPrice":2.15,"bidSize":421,"shortable":3,"etf":0,"ttmEps":-10.239864,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":4,"symbolChange":{"newSymbol":"SKYED","executeDate":"2023-09-08"},"adr":0,"exchange":"NASDAQ","adjPreClose":1.99,"preHourTrading":{"tag":"盘前","latestPrice":1.87,"preClose":1.99,"latestTime":"09:19 EDT","volume":16,"amount":31.1357008,"timestamp":1789478354753,"change":-0.12,"changeRate":-0.060302,"amplitude":0.163367},"postHourTrading":{"tag":"盘后","latestPrice":2.15,"preClose":2.11,"latestTime":"19:19 EDT","volume":187,"amount":401.730043,"timestamp":1789514344945,"change":0.04,"changeRate":0.018957,"amplitude":0.018957},"volumeRatio":0.414081,"impliedVol":0.9132,"impliedVolPercentile":0.2415},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SKYE\",,,,,undefined,":{"symbol":"SKYE","floatShares":2868950,"roa":"-95.06%","roe":"-233.87%","lyrEps":-11.280088,"volumeRatio":0.414081,"shares":4390860,"dividePrice":0,"high":2.11,"amplitude":0.105528,"preClose":1.99,"low":1.9,"week52Low":1.64,"pbRate":"-18.63","week52High":39.9216,"institutionHeld":0,"latestPrice":2.11,"committee":0.677291,"eps":-10.239864,"divideRate":0,"volume":36993,"delay":0,"ttmEps":-10.239864,"open":1.97,"prevYearClose":5.9976,"prevWeekClose":2.04,"prevMonthClose":1.68,"prevQuarterClose":5.5464,"fiveDayClose":1.88,"twentyDayClose":3.3208,"sixtyDayClose":5.6584},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SKYE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-24","symbol":"SKYE","defaultRemindTime":1787578200000,"type":"split","dateTimestamp":1787544000000,"forFactor":8,"toFactor":1,"ratio":8},{"market":"US","date":"2026-08-14","symbol":"SKYE","fiscalQuarterEnding":"2026/06","expectedEps":-0.29,"name":null,"time":"","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"","actualEps":-0.27},{"market":"US","date":"2026-05-11","symbol":"SKYE","fiscalQuarterEnding":"2026/03","expectedEps":-0.29,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778472000000,"reportTimeType":"post","actualEps":-0.32},{"market":"US","date":"2026-03-10","symbol":"SKYE","fiscalQuarterEnding":"2025/12","expectedEps":-0.29,"name":null,"time":"盤後","type":"earning","dateTimestamp":1773115200000,"reportTimeType":"post","actualEps":-0.36},{"market":"US","date":"2025-11-10","symbol":"SKYE","fiscalQuarterEnding":"2025/09","expectedEps":-0.33,"name":null,"time":"盤後","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"post","actualEps":-0.32}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SKYE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SKYE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6,"hold":0.4,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1759982400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SKYE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SKYE","date":"2026-09-14","current":-0.194339,"percent":0.983022,"low":-12.94129,"twenty":-4.244961,"median":-2.398747,"eighty":-0.482435,"high":-0.147319,"avg":-2.841604,"sd":2.609584,"marketCap":9032459},"quantilePoints":[{"date":"2024-04-12","current":-9.459964,"twenty":-9.513638,"median":-9.459964,"eighty":-7.885539,"marketCap":356118289},{"date":"2024-04-19","current":-12.650558,"twenty":-12.435864,"median":-9.657512,"eighty":-9.495746,"marketCap":476227531},{"date":"2024-04-26","current":-9.579238,"twenty":-12.081022,"median":-9.691058,"eighty":-9.561347,"marketCap":360608354},{"date":"2024-05-03","current":-9.683603,"twenty":-11.635233,"median":-9.68733,"eighty":-9.561347,"marketCap":364537161},{"date":"2024-05-10","current":-8.997775,"twenty":-10.807766,"median":-9.638876,"eighty":-9.507673,"marketCap":338719287},{"date":"2024-05-17","current":-9.168,"twenty":-10.15772,"median":-9.601602,"eighty":-9.22813,"marketCap":343770610},{"date":"2024-05-24","current":-8.952556,"twenty":-9.700003,"median":-9.54942,"eighty":-8.9931,"marketCap":335692167},{"date":"2024-05-31","current":-8.720508,"twenty":-9.691058,"median":-9.489815,"eighty":-8.983995,"marketCap":326991116},{"date":"2024-06-07","current":-8.47349,"twenty":-9.691058,"median":-9.389145,"eighty":-8.952556,"marketCap":317728707},{"date":"2024-06-14","current":-8.069277,"twenty":-9.691058,"median":-9.18753,"eighty":-8.690567,"marketCap":302572037},{"date":"2024-06-21","current":-6.684476,"twenty":-9.685094,"median":-9.060284,"eighty":-8.473188,"marketCap":250646409},{"date":"2024-06-28","current":-5.434411,"twenty":-9.674658,"median":-9.022864,"eighty":-8.245631,"marketCap":203773004},{"date":"2024-07-05","current":-5.58412,"twenty":-9.638876,"median":-8.993879,"eighty":-7.844715,"marketCap":209386586},{"date":"2024-07-12","current":-4.873005,"twenty":-9.631421,"median":-8.980898,"eighty":-7.11863,"marketCap":182722074},{"date":"2024-07-15","current":-4.820607,"twenty":-9.62993,"median":-8.974213,"eighty":-6.892464,"marketCap":180757321},{"date":"2024-08-02","current":-4.102007,"twenty":-9.628439,"median":-8.967527,"eighty":-6.745055,"marketCap":153812130},{"date":"2024-08-09","current":-3.735222,"twenty":-9.606075,"median":-8.870216,"eighty":-5.58412,"marketCap":140058855},{"date":"2024-08-16","current":-3.615791,"twenty":-9.579238,"median":-8.690567,"eighty":-4.690361,"marketCap":152904981},{"date":"2024-08-23","current":-3.787972,"twenty":-9.567311,"median":-8.506414,"eighty":-4.17237,"marketCap":160186171},{"date":"2024-08-30","current":-4.584307,"twenty":-9.543456,"median":-8.189044,"eighty":-4.185844,"marketCap":193861673},{"date":"2024-09-06","current":-4.347559,"twenty":-9.525571,"median":-8.069277,"eighty":-4.204574,"marketCap":183850037},{"date":"2024-09-13","current":-4.304513,"twenty":-9.489808,"median":-7.545298,"eighty":-4.204574,"marketCap":182029740},{"date":"2024-09-20","current":-3.93863,"twenty":-9.483818,"median":-7.11863,"eighty":-4.170873,"marketCap":166557212},{"date":"2024-09-27","current":-2.840979,"twenty":-9.431636,"median":-6.35886,"eighty":-4.072065,"marketCap":120139628},{"date":"2024-10-04","current":-2.56836,"twenty":-9.296072,"median":-5.58412,"eighty":-3.802872,"marketCap":108611078},{"date":"2024-10-11","current":-2.683147,"twenty":-9.199248,"median":-5.224584,"eighty":-3.740033,"marketCap":113465204},{"date":"2024-10-18","current":-3.034682,"twenty":-9.153032,"median":-4.873005,"eighty":-3.308736,"marketCap":128330966},{"date":"2024-10-25","current":-3.501004,"twenty":-9.080009,"median":-4.593919,"eighty":-3.325954,"marketCap":148050855},{"date":"2024-10-31","current":-3.651662,"twenty":-9.02741,"median":-4.557114,"eighty":-3.343172,"marketCap":154421896},{"date":"2024-11-08","current":-7.770049,"twenty":-9.018318,"median":-4.55561,"eighty":-3.379043,"marketCap":165040297},{"date":"2024-11-15","current":-7.870031,"twenty":-8.997775,"median":-4.571462,"eighty":-3.501004,"marketCap":167163977},{"date":"2024-11-22","current":-5.956085,"twenty":-8.989983,"median":-4.820607,"eighty":-3.501004,"marketCap":126510669},{"date":"2024-11-29","current":-6.413147,"twenty":-8.983995,"median":-4.921494,"eighty":-3.53544,"marketCap":136218922},{"date":"2024-12-06","current":-5.070528,"twenty":-8.981218,"median":-5.25247,"eighty":-3.595703,"marketCap":107700929},{"date":"2024-12-13","current":-4.784865,"twenty":-8.970201,"median":-5.21336,"eighty":-3.614356,"marketCap":101633271},{"date":"2024-12-20","current":-4.084989,"twenty":-8.95555,"median":-5.042643,"eighty":-3.644488,"marketCap":86767509},{"date":"2024-12-27","current":-3.799325,"twenty":-8.952556,"median":-4.89725,"eighty":-3.64221,"marketCap":80699851},{"date":"2025-01-03","current":-4.070706,"twenty":-8.886684,"median":-4.82416,"eighty":-3.64221,"marketCap":86464126},{"date":"2025-01-10","current":-4.427785,"twenty":-8.774403,"median":-4.734873,"eighty":-3.64221,"marketCap":94048699},{"date":"2025-01-17","current":-3.856458,"twenty":-8.71452,"median":-4.60353,"eighty":-3.6441,"marketCap":81913383},{"date":"2025-01-24","current":-3.727909,"twenty":-8.690567,"median":-4.558618,"eighty":-3.651662,"marketCap":79182936},{"date":"2025-01-31","current":-5.356192,"twenty":-8.660625,"median":-4.557114,"eighty":-3.694707,"marketCap":113768587},{"date":"2025-02-07","current":-4.256387,"twenty":-8.539337,"median":-4.55561,"eighty":-3.699343,"marketCap":90408104},{"date":"2025-02-14","current":-4.370652,"twenty":-8.47349,"median":-4.466458,"eighty":-3.699343,"marketCap":92835167},{"date":"2025-02-21","current":-4.470635,"twenty":-8.472282,"median":-4.477777,"eighty":-3.722196,"marketCap":94958847},{"date":"2025-02-28","current":-3.827892,"twenty":-8.245631,"median":-4.442068,"eighty":-3.730044,"marketCap":81306617},{"date":"2025-03-07","current":-3.670777,"twenty":-8.162365,"median":-4.40636,"eighty":-3.699343,"marketCap":77969405},{"date":"2025-03-14","current":-3.463671,"twenty":-8.134468,"median":-4.354733,"eighty":-3.698416,"marketCap":73570353},{"date":"2025-03-21","current":-2.203547,"twenty":-8.081254,"median":-4.304513,"eighty":-3.649772,"marketCap":58541914},{"date":"2025-03-28","current":-2.471704,"twenty":-7.90988,"median":-4.297339,"eighty":-3.6255,"marketCap":65666062},{"date":"2025-04-04","current":-1.632257,"twenty":-7.858605,"median":-4.256387,"eighty":-3.582221,"marketCap":43364381},{"date":"2025-04-11","current":-1.562303,"twenty":-7.846922,"median":-4.225597,"eighty":-3.501004,"marketCap":41505907},{"date":"2025-04-17","current":-1.842119,"twenty":-7.799915,"median":-4.189726,"eighty":-3.364695,"marketCap":48939801},{"date":"2025-04-25","current":-2.086958,"twenty":-7.727199,"median":-4.165203,"eighty":-3.259602,"marketCap":55444458},{"date":"2025-05-02","current":-2.366773,"twenty":-7.630073,"median":-4.156405,"eighty":-3.056205,"marketCap":62878352},{"date":"2025-05-09","current":-1.698098,"twenty":-7.560926,"median":-4.127838,"eighty":-2.911286,"marketCap":55444458},{"date":"2025-05-16","current":-1.907406,"twenty":-7.545298,"median":-4.116978,"eighty":-2.799369,"marketCap":62278559},{"date":"2025-05-23","current":-1.964344,"twenty":-7.500386,"median":-4.077848,"eighty":-2.746856,"marketCap":64137621},{"date":"2025-05-30","current":-2.011792,"twenty":-7.329718,"median":-4.070706,"eighty":-2.683147,"marketCap":65686838},{"date":"2025-06-06","current":-2.040261,"twenty":-7.099247,"median":-4.06458,"eighty":-2.616276,"marketCap":66616369},{"date":"2025-06-13","current":-2.05924,"twenty":-6.976473,"median":-4.013573,"eighty":-2.54373,"marketCap":67236056},{"date":"2025-06-20","current":-2.030771,"twenty":-6.805634,"median":-3.979786,"eighty":-2.387759,"marketCap":66306526},{"date":"2025-06-27","current":-4.033073,"twenty":-6.650207,"median":-3.970723,"eighty":-2.387759,"marketCap":131683521},{"date":"2025-07-03","current":-4.374698,"twenty":-6.513129,"median":-3.970723,"eighty":-2.471704,"marketCap":142837890},{"date":"2025-07-11","current":-3.738896,"twenty":-6.413147,"median":-3.970723,"eighty":-2.503792,"marketCap":122078370},{"date":"2025-07-18","current":-3.530125,"twenty":-6.413147,"median":-3.966646,"eighty":-2.541658,"marketCap":115261811},{"date":"2025-07-25","current":-3.805323,"twenty":-6.298881,"median":-3.947535,"eighty":-2.546837,"marketCap":124247275},{"date":"2025-08-01","current":-3.387782,"twenty":-6.198899,"median":-3.902759,"eighty":-2.561185,"marketCap":110614158},{"date":"2025-08-08","current":-3.368802,"twenty":-6.1132,"median":-3.885025,"eighty":-2.56836,"marketCap":109994470},{"date":"2025-08-15","current":-2.391434,"twenty":-6.1132,"median":-3.856458,"eighty":-2.546837,"marketCap":101332133},{"date":"2025-08-22","current":-2.596205,"twenty":-6.1132,"median":-3.856458,"eighty":-2.541658,"marketCap":110008891},{"date":"2025-08-29","current":-2.545012,"twenty":-6.033244,"median":-3.838191,"eighty":-2.530385,"marketCap":107839701},{"date":"2025-09-05","current":-2.74247,"twenty":-6.003302,"median":-3.805323,"eighty":-2.498872,"marketCap":116206575},{"date":"2025-09-12","current":-3.115445,"twenty":-5.964031,"median":-3.793648,"eighty":-2.525066,"marketCap":132010669},{"date":"2025-09-19","current":-2.881421,"twenty":-5.898952,"median":-3.776855,"eighty":-2.539403,"marketCap":122094374},{"date":"2025-09-26","current":-2.632771,"twenty":-5.861816,"median":-3.757875,"eighty":-2.544341,"marketCap":111558312},{"date":"2025-10-03","current":-3.28365,"twenty":-5.684705,"median":-3.738896,"eighty":-2.546472,"marketCap":139138005},{"date":"2025-10-10","current":-1.257879,"twenty":-5.595667,"median":-3.729992,"eighty":-2.525066,"marketCap":53300082},{"date":"2025-10-17","current":-1.060422,"twenty":-5.58412,"median":-3.727909,"eighty":-2.468814,"marketCap":44933209},{"date":"2025-10-24","current":-1.060422,"twenty":-5.516043,"median":-3.699343,"eighty":-2.388509,"marketCap":44933209},{"date":"2025-10-31","current":-1.075048,"twenty":-5.447334,"median":-3.691448,"eighty":-2.317303,"marketCap":45552977},{"date":"2025-11-07","current":-1.111614,"twenty":-5.371836,"median":-3.676368,"eighty":-2.244599,"marketCap":47102398},{"date":"2025-11-14","current":-0.828708,"twenty":-5.321912,"median":-3.651662,"eighty":-2.178806,"marketCap":42454135},{"date":"2025-11-21","current":-0.782205,"twenty":-5.233356,"median":-3.64221,"eighty":-2.124921,"marketCap":40071826},{"date":"2025-11-28","current":-0.819751,"twenty":-5.18765,"median":-3.621859,"eighty":-2.093402,"marketCap":41995273},{"date":"2025-12-05","current":-0.757174,"twenty":-5.110521,"median":-3.608617,"eighty":-2.055444,"marketCap":38789527},{"date":"2025-12-12","current":-0.719628,"twenty":-5.037066,"median":-3.577936,"eighty":-2.025264,"marketCap":36866080},{"date":"2025-12-19","current":-0.625701,"twenty":-4.9588,"median":-3.549105,"eighty":-1.981949,"marketCap":32054255},{"date":"2025-12-26","current":-0.522137,"twenty":-4.912548,"median":-3.544049,"eighty":-1.945365,"marketCap":26748745},{"date":"2026-01-02","current":-0.469135,"twenty":-4.89913,"median":-3.530125,"eighty":-1.880836,"marketCap":24033478},{"date":"2026-01-09","current":-0.657052,"twenty":-4.893905,"median":-3.501657,"eighty":-1.841207,"marketCap":33660334},{"date":"2026-01-16","current":-0.60236,"twenty":-4.863947,"median":-3.501004,"eighty":-1.780246,"marketCap":30858511},{"date":"2026-01-23","current":-0.657052,"twenty":-4.827714,"median":-3.463671,"eighty":-1.698098,"marketCap":33660334},{"date":"2026-01-30","current":-0.600733,"twenty":-4.820607,"median":-3.430485,"eighty":-1.632257,"marketCap":30775162},{"date":"2026-02-06","current":-0.500298,"twenty":-4.784865,"median":-3.387782,"eighty":-1.562303,"marketCap":25629940},{"date":"2026-02-13","current":-0.451176,"twenty":-4.684882,"median":-3.355987,"eighty":-1.389518,"marketCap":23113429},{"date":"2026-02-20","current":-0.488221,"twenty":-4.650603,"median":-3.310888,"eighty":-1.249103,"marketCap":25011231},{"date":"2026-02-27","current":-0.482464,"twenty":-4.611231,"median":-3.270848,"eighty":-1.139404,"marketCap":24716302},{"date":"2026-03-06","current":-0.461814,"twenty":-4.588626,"median":-3.232166,"eighty":-1.117465,"marketCap":23658406},{"date":"2026-03-13","current":-0.421973,"twenty":-4.584426,"median":-3.115445,"eighty":-1.099913,"marketCap":23598786},{"date":"2026-03-20","current":-0.391057,"twenty":-4.563756,"median":-3.07414,"eighty":-1.060422,"marketCap":21869766},{"date":"2026-03-27","current":-0.368854,"twenty":-4.556212,"median":-3.020373,"eighty":-1.032631,"marketCap":20628076},{"date":"2026-04-02","current":-0.396846,"twenty":-4.55561,"median":-3.01306,"eighty":-0.904924,"marketCap":22193540},{"date":"2026-04-10","current":-0.433194,"twenty":-4.547475,"median":-2.991518,"eighty":-0.825125,"marketCap":24226306},{"date":"2026-04-17","current":-0.447638,"twenty":-4.524911,"median":-2.934243,"eighty":-0.813493,"marketCap":25034073},{"date":"2026-04-24","current":-0.564544,"twenty":-4.496344,"median":-2.903361,"eighty":-0.760929,"marketCap":31572043},{"date":"2026-05-01","current":-0.551982,"twenty":-4.476348,"median":-2.874108,"eighty":-0.754671,"marketCap":30869505},{"date":"2026-05-08","current":-0.56423,"twenty":-4.457052,"median":-2.850745,"eighty":-0.717125,"marketCap":31554479},{"date":"2026-05-15","current":-0.533788,"twenty":-4.44444,"median":-2.837542,"eighty":-0.67958,"marketCap":30602541},{"date":"2026-05-22","current":-0.4379,"twenty":-4.441321,"median":-2.797934,"eighty":-0.658929,"marketCap":25105183},{"date":"2026-05-29","current":-0.520738,"twenty":-4.435608,"median":-2.76565,"eighty":-0.638279,"marketCap":29854338},{"date":"2026-06-05","current":-0.474724,"twenty":-4.410645,"median":-2.74247,"eighty":-0.632021,"marketCap":27216309},{"date":"2026-06-12","current":-0.489857,"twenty":-4.380841,"median":-2.71105,"eighty":-0.613399,"marketCap":28083943},{"date":"2026-06-18","current":-0.435939,"twenty":-4.374698,"median":-2.686734,"eighty":-0.608898,"marketCap":24992777},{"date":"2026-06-26","current":-0.434248,"twenty":-4.373889,"median":-2.681566,"eighty":-0.585144,"marketCap":24895812},{"date":"2026-07-02","current":-0.413897,"twenty":-4.370652,"median":-2.632771,"eighty":-0.575703,"marketCap":23729041},{"date":"2026-07-10","current":-0.429651,"twenty":-4.354733,"median":-2.616316,"eighty":-0.564126,"marketCap":24632234},{"date":"2026-07-17","current":-0.385331,"twenty":-4.347559,"median":-2.596205,"eighty":-0.550977,"marketCap":22091343},{"date":"2026-07-24","current":-0.413774,"twenty":-4.304513,"median":-2.571313,"eighty":-0.54187,"marketCap":23722012},{"date":"2026-07-31","current":-0.355723,"twenty":-4.304513,"median":-2.566952,"eighty":-0.531458,"marketCap":20393901},{"date":"2026-08-07","current":-0.289151,"twenty":-4.300292,"median":-2.559638,"eighty":-0.518052,"marketCap":16577293},{"date":"2026-08-14","current":-0.331632,"twenty":-4.297719,"median":-2.545924,"eighty":-0.506842,"marketCap":19012753},{"date":"2026-08-21","current":-0.195163,"twenty":-4.274381,"median":-2.530385,"eighty":-0.500548,"marketCap":9854299},{"date":"2026-08-28","current":-0.170995,"twenty":-4.258838,"median":-2.475536,"eighty":-0.496719,"marketCap":8633968},{"date":"2026-09-04","current":-0.156088,"twenty":-4.256387,"median":-2.457253,"eighty":-0.488196,"marketCap":7881263},{"date":"2026-09-11","current":-0.182394,"twenty":-4.247817,"median":-2.40606,"eighty":-0.484829,"marketCap":9209566},{"date":"2026-09-14","current":-0.178887,"twenty":-4.244961,"median":-2.398747,"eighty":-0.482435,"marketCap":9032459}],"updateTime":1789473422145},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SKYE\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1113240693","title":"Skye Bioscience Inc.首席財務官John P. Sharp宣佈辭職，9月8日正式生效，SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1113240693","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113240693?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 04:15","pubTimestamp":1789157710,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会的最新文件披露，Skye Bioscience Inc.宣布了一项重要人事变动。公司首席财务官兼主要财务负责人John P. Sharp已正式提交辞呈。这一人事调整将于2026年9月8日正式生效。此番高管变动消息通过SEC的官方申报文件公之于众，引发市场关注。据悉，Sharp的离职生效日期已明确锁定在2026年9月8日。截至目前，Skye Bioscience Inc.尚未就新任CFO的任命事宜发布进一步说明。投资者正密切关注公司后续的应对举措与管理层补位进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182683501","title":"Skye Bioscience與Redmile Biopharma Investments III簽署2200萬美元證券購買協議——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1182683501","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182683501?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 04:04","pubTimestamp":1787601850,"startTime":"0","endTime":"0","summary":"Skye Bioscience Inc.日前通过美国证券交易委员会文件正式披露，该公司已与Redmile Biopharma Investments III达成一项价值2200万美元的证券购买协议。这一战略性融资安排标志着Skye Bioscience在生物制药领域的发展迈出了重要一步。根据协议条款，Redmile Biopharma Investments III将以认购方式参与本轮融资。证券购买协议的签署，意味着Skye Bioscience将获得用于推进其核心研发项目、扩大临床试验规模以及补充营运资金的重要财务资源。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118976368","title":"Skye Bioscience：合併後公司現金儲備預計可支撐運營至2029年，Rxc008二期數據預計2028年下半年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1118976368","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118976368?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 21:39","pubTimestamp":1786714767,"startTime":"0","endTime":"0","summary":"Skye Bioscience Inc. 宣布，合并后的公司现金储备预计将足以维持运营至2029年。同时，其核心药物候选Rxc008的二期临床数据，预计将在2028年下半年对外公布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136838339","title":"Skye Bioscience股東將獲CVR：交易結束後12個月內有權收取Nimacimab淨收益的90%","url":"https://stock-news.laohu8.com/highlight/detail?id=1136838339","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136838339?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 21:38","pubTimestamp":1786714705,"startTime":"0","endTime":"0","summary":"Skye Bioscience宣布，其股东将在交易完成后的12个月内，获得一项或有价值权（CVR），该权益涵盖Nimacimab项目净收益的90%。这一安排为投资者提供了明确的收益分配机制，旨在确保股东能够从该资产未来的商业化成果中直接受益。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130885897","title":"Skye Bioscience交易後股權結構：Skye持股5.38%，Redx持46.17%，融資投資者持48.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=1130885897","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130885897?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 21:36","pubTimestamp":1786714569,"startTime":"0","endTime":"0","summary":"Skye Bioscience Inc.在交易完成后的新公司中，其自身持股比例仅为5.38%。相比之下，Redx的持股比例高达46.17%，而参与融资的投资者则总计持有48.45%的股份。这一股权分配格局，清晰揭示了各方在合并实体中的权重大小。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199526390","title":"Skye Bioscience Inc. - 臨床研究委員會批准啓動第二組（600毫克靜脈注射）入組，此前第一組安全性評估結果良好","url":"https://stock-news.laohu8.com/highlight/detail?id=1199526390","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199526390?lang=zh_tw&edition=fundamental","pubTime":"2026-05-20 19:01","pubTimestamp":1779274904,"startTime":"0","endTime":"0","summary":"在完成对第一组受试者的安全性评估并获得良好反馈后，临床研究委员会已正式批准Skye Bioscience Inc.启动其研究项目的第二组患者入组工作。该组别将采用600毫克的静脉注射剂量方案。这一决定标志着该药物临床开发进程向前迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SKYE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155074624","title":"Skye宣佈基於隊列1前四名受試者良好安全性數據，隊列評審委員會批准開啓隊列2","url":"https://stock-news.laohu8.com/highlight/detail?id=1155074624","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155074624?lang=zh_tw&edition=fundamental","pubTime":"2026-05-20 19:00","pubTimestamp":1779274829,"startTime":"0","endTime":"0","summary":"Skye Bioscience Inc. 宣布，其队列评审委员会已批准开启临床试验的队列2。这一决定是基于从队列1中首批接受治疗的四名参与者所获得的积极安全性数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634298470","title":"美國研究綜述-Accuray、Aevex、Zoetis","url":"https://stock-news.laohu8.com/highlight/detail?id=2634298470","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634298470?lang=zh_tw&edition=fundamental","pubTime":"2026-05-12 15:22","pubTimestamp":1778570557,"startTime":"0","endTime":"0","summary":"美国研究综述-Accuray、Aevex、Zoetis路透5月12日 - 周二，华尔街的证券分析师们下调了多家在美国上市公司的评级和目标股价，其中包括Accuray、Aevex和Zoetis。股票按字母顺序排列。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL4T41P0LY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000338","GTM","TGT","TOST","ZTS","ELVN","PLNT","APO","BN","ASTH","ARES","AGM","AMAT","IE00BFXG1179.USD","CYTK","HIMY","HMYY","SPG","CGNX","MOS","VCTR","KKR","HIMS","HIYY","BAM","CEVA","ARAY","PSIX","WPC","LU1244550221.USD","LQDA","BX","BILL","SGI","SKYE","TXG","CVS","VSNT","SNDA","HIMZ","LENZ","BK4585","LU1496350171.SGD","LU2023250504.SGD","SIBN","TRGP","ALMR","AVEX","FTV","CE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624034688","title":"BUZZ--美國股票走勢-特斯拉、藍貓頭鷹、福特","url":"https://stock-news.laohu8.com/highlight/detail?id=2624034688","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624034688?lang=zh_tw&edition=fundamental","pubTime":"2026-04-02 23:49","pubTimestamp":1775144981,"startTime":"0","endTime":"0","summary":".N美国东部时间11:30，道琼斯工业平均指数.DJI下跌0.11%，报46,514.09点；标普500指数.SPX上涨0.03%，报6,577.02点；纳斯达克综合指数.IXIC下跌0.02%，报21,836.06点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nL4T40L1HD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OXY","XOMZ","SCCO","XOMX","LMT","EL","CDE","LNN","TSLA","HMH","DAL","NWMX","RVNL","SKYE","TSLY","TSLR","TSLO","WING","AALG","HL","OWL","XOM","CVX","KRP","SBH","INO","IMVT","TESL","TSDD","JBHT","SNBR","COP","LUV","TSLQ","XOMO","TSLI","DVN","FCX","GSAT","LPCN","NOC","RIVN","CLDX","UAL","07766","TSLP","AAL","CNTX","NEM","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624505203","title":"BUZZ-斯凱生物科學公司開始測試更大劑量的肥胖症藥物，業績上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2624505203","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624505203?lang=zh_tw&edition=fundamental","pubTime":"2026-04-02 19:45","pubTimestamp":1775130345,"startTime":"0","endTime":"0","summary":"BUZZ-斯凯生物科学公司开始测试更大剂量的肥胖症药物，业绩上升4月2日 - ** 生物技术公司斯凯生物科学SKYE.O股价盘前上涨1.2%至0.67美元** 该公司称已开始在一项新的扩展研究中测试其试验性肥胖症药物尼马单抗的更高剂量 ** 补充说，这项研究将在16周内测试400毫克和600毫克的静脉注射剂量，以检查药物的安全性以及药物在体内的移动情况，并与安慰剂进行对比。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nL4S40L0YS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SKYE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196567670","title":"Skye Bioscience啓動尼瑪西單抗高劑量擴展研究首位患者給藥 評估暴露-反應為GLP-1聯合療法二期B階段劑量選擇提供依據","url":"https://stock-news.laohu8.com/highlight/detail?id=1196567670","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196567670?lang=zh_tw&edition=fundamental","pubTime":"2026-04-02 19:02","pubTimestamp":1775127720,"startTime":"0","endTime":"0","summary":"生物制药企业Skye Bioscience Inc. (NASDAQ: SKYE) 近日迎来重大研发进展——其针对尼玛西单抗（nimacimab）开展的高剂量扩展研究已完成首例患者给药。该研究旨在通过评估药物暴露-反应关系，为后续GLP-1联合疗法的二期B阶段临床实验确定最佳剂量方案提供关键数据支持。\n此次剂量扩展研究的启动，标志着Skye Bioscience在代谢性疾病治疗领域迈出实质性步伐。通过精准分析不同剂量水平下尼玛西单抗在人体内的代谢动力学与药效学关联，研究团队期望为二期B阶段剂量选择奠定科学基础，进而加速GLP-1受体激动剂联合疗法的开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SKYE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}]}}